NuvOx Therapeutics, Inc. — Form D
NuvOx Therapeutics, Inc. of TUCSON, AZ, a company, filed a Form D exempt-offering notice with the SEC on 2023-02-15. The offering totals $5.0M, of which $1.1M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-02-15
- Form: D
- Accession: 0001966126-23-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $1.1M
- Remaining: $4.0M
- Minimum investment: $50K
- Investors: 2
- Date of first sale: 2023-01-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-473594
Issuer
- Name: NuvOx Therapeutics, Inc.
- CIK: 0001966126
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1635 E. 18TH STREET, TUCSON, AZ, 85719
- Phone: (520) 624-6688
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| Richard C Carmona | Director | Tucson, AZ |
| Jon C Saxe | Director | Tucson, AZ |
| Jonathan C Schilling | Director | Tucson, AZ |
| Marvin C Slepian | Director | Tucson, AZ |
| Evan C Unger | Director | Tucson, AZ |
| Evan C Unger | Executive Officer | Tucson, AZ |
| Rong C Wang | Executive Officer | Tucson, AZ |
| Jon Saxe | Director | Mountain View, CA |
| Jennifer Johnson | Executive Officer | NEW YORK, NY |
| Marvin J Slepian | Director | Tucson, AZ |
| Richard T Carmona | Director | Tucson, AZ |
| Jonathan T Schilling | Director | Tucson, AZ |
| Rong Wang | Executive Officer | Tucson, AZ |
| Evan Unger | Director | Tucson, AZ |
| Evan Unger | Executive Officer | Tucson, AZ |
Other filings by this issuer (1)
More